BT Slingsby

Dr. BT Slingsby is CEO and executive director of the GHIT Fund. Previously, he was director for Global Access Strategies for Eisai Co., Ltd. where he developed new business models for R&D and market access in the developing world. Prior to joining Eisai Co., Ltd., he helped launch numerous startups in Japan and the U.S.

Latest Articles

How innovative financing and partnerships are transforming the infectious disease product pipeline

about 10 years ago // #innov8aid

Through the Global Health Innovative Technology Fund, the Japanese works with pharmaceutical companies and nonprofits to boost investment in the research and development of game-changing drugs for the world's deadliest diseases. GHIT CEO and Executive Director BT Slingsby explains how the fund works.

See all articles by BT Slingsby